Scarica l'app Stockscreener
3.32
3.77%
-0.13
Pre-mercato:
3.22
-0.10
-3.01%
Prime Medicine Inc Borsa (PRME) Ultime notizie
Aug Analyst Calls: Is Prime Medicine Inc stock a smart retirement pick2025 Biggest Moves & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Prime Medicine, Inc. (NYSE:PRME) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Earnings Miss: Will Prime Medicine Inc stock hit new highs in YEARJuly 2025 Spike Watch & AI Driven Price Forecasts - baoquankhu1.vn
Prime Medicine Advances Wilson Disease Pipeline With New Prescreening Study - TipRanks
Institutional Owners May Ignore Prime Medicine, Inc.'s (NASDAQ:PRME) Recent US$66m Market Cap Decline as Longer-term Profits Stay in the Green - 富途牛牛
Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$110m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
What is the target price for Prime Medicine Inc. stockJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - mfd.ru
Aug Selloffs: Should I average down on Prime Medicine Inc stockJuly 2025 Drop Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Favourable Signals For Prime Medicine: Numerous Insiders Acquired Stock - Yahoo Finance
Prime Medicine (NASDAQ:PRME) Shares Down 5.6%What's Next? - MarketBeat
Prime Medicine (NYSE:PRME) Trading Down 5.5%What's Next? - MarketBeat
JonesTrading Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
Prime Medicine (NASDAQ:PRME) Shares Up 10.5%Here's Why - MarketBeat
Prime Medicine (NYSE:PRME) Shares Up 12.4%Time to Buy? - MarketBeat
Should I trade or invest in Prime Medicine IncJuly 2025 Highlights & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Targets Report: Is NEOV in accumulation or distribution phaseGap Down & Weekly Breakout Stock Alerts - baoquankhu1.vn
How Prime Medicine Inc. stock reacts to bond yieldsEarnings Trend Report & Long-Term Safe Return Strategies - bollywoodhelpline.com
Sumitomo Mitsui Trust Group Inc. Boosts Stake in Prime Medicine, Inc. $PRME - MarketBeat
Prime Medicine (NASDAQ:PRME) Trading Down 7.9%Should You Sell? - MarketBeat
Prime Medicine (NYSE:PRME) Trading Down 5.7%What's Next? - MarketBeat
Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Prime Medicine (NASDAQ:PRME) Shares Up 8.4%Should You Buy? - MarketBeat
Prime Medicine updates corporate strategy for Prime Editing platform - TipRanks
Prime Medicine, Inc. Updates on Prime Editing Developments - TradingView
What technical charts say about Prime Medicine Inc. stock2025 Market Overview & Verified Chart Pattern Signals - Улправда
Is Prime Medicine Inc. stock a safe buy before earningsJuly 2025 Outlook & Technical Entry and Exit Tips - Улправда
How Prime Medicine Inc. stock benefits from tech adoptionWeekly Market Summary & Weekly Return Optimization Alerts - ulpravda.ru
What hedge fund activity signals for Prime Medicine Inc. stockIndex Update & AI Based Buy/Sell Signal Reports - ulpravda.ru
Prime Medicine initiated with an outperform at LifeSci Capital - MSN
Los Angeles Daily NewsPrime Medicine, Inc.Common Stock (Nasdaq:PRME) Stock Quote - FinancialContent
Prime Medicine (NYSE:PRME) Trading 7.5% HigherWhat's Next? - MarketBeat
How Prime Medicine Inc. stock reacts to oil pricesBullish Engulfing Patterns & High Profit Trading Alerts - Улправда
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
WaterWorldPrime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - FinancialContent
Prime Medicine, Inc. (PRME) announces NEJM publication of PM359 data - MSN
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize - Benzinga
Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond - Seeking Alpha
Prime Medicine (NYSE:PRME) Trading Down 3.3%Here's What Happened - MarketBeat
LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases - Insider Monkey
Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data - Insider Monkey
10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey
Lifesci Capital Predicts Prime Medicine FY2025 Earnings - MarketBeat
Prime Medicine (NASDAQ:PRME) Trading Down 3.8%Here's What Happened - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 4.2%Should You Sell? - MarketBeat
Prime Medicine (NASDAQ:PRME) Upgraded at Lifesci Capital - MarketBeat
LifeSci Capital Initiates Coverage of Prime Medicine (PRME) with Outperform Recommendation - Nasdaq
Lifesci Capital Begins Coverage on Prime Medicine (NYSE:PRME) - MarketBeat
LifeSci Capital Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $6 - 富途牛牛
Prime Medicine: Buy Rating on Prime Editing Platform Targeting High-Value Liver and Lung Genetic Diseases, Led by PM577 in Wilson’s Disease - TipRanks
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):